Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|July 1, 1988
Dinucleotide analogues as inhibitors of thymidine kinase, thymidylate kinase, and ribonucleotide reductaseL C Davies, J A Stock, S E Barrie, et al.The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1994
Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase)S E Barrie, G A Potter, P M Goddard, et al.Journal of Medicinal Chemistry|October 13, 1995
Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysisM G Rowlands, S E Barrie, F Chan, et al.Journal of Enzyme Inhibition|January 1, 1994
Evaluation of some 4-fluoro- and 4-cyano derivatives of delta 4,3-ketosteroids as inhibitors of testosterone 5 alpha-reductaseM Jarman, S E Barrie, J Houghton, et al.Journal of Medicinal Chemistry|August 16, 1996
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancerF C Chan, G A Potter, S E Barrie, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1997
Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitorsS E Barrie, B P Haynes, G A Potter, et al.European Journal of Cancer & Clinical Oncology|May 1, 1986
5-Ethyl-2'-deoxyuridine: an explanation for its lack of cytotoxic action in vivoA Jeney, S E Barrie, G A Taylor, et al.Pageof 2